Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)

Inclusion Criteria:

• Subjects who agree to the terms described in IC;

• Subjects of both genders, aged ≥ 18 and ≤ 75 years with IVC framework of the lowerlimbs;

• Subjects with CVI ranked 3 to 5, according to CEAP scale;

• Patients complaining of pain and swelling in the lower limbs secondary to IVC;

• Subjects with good mental health that can respond adequately to the studyquestionnaires;

• Subjects who agree to make any return visits for evaluation;

Exclusion Criteria:

• Patients with CVI classified as 0, 1, 2 or 6, according to CEAP;

• Subjects who have received treatment for varicose veins as laser, medication usetopical or oral (eg: brown India, coumarin, and etc.). And surgery in the 03 monthspreceding the study;

• Patients with other diseases that may interfere with the study results: thrombosis,coagulation disorders and other diseases that the medical criteria, are important tobe excluded;

• Pregnant or nursing women;

• Presence of any medical condition that, according to the investigator, should preventthe patient from the study;

• Participation in clinical trials in the twelve months preceding the study;

• Patients with serious illnesses and uncontrolled that need multidrug treatment;

• Patients on diuretics of any kind, regardless of pathology (hypertension, renal orliver disease);

• Values of laboratory tests appropriate security; the Hemoglobin <10 mg / mL thecreatinine> 1.5 mg / mL; AST, ALT, GGT ≥ 2 times normal values; the platelet countbelow 90.000/ml; Total Bilirubin and the fractions ≤ 1.5 times the normal range.

• past medical history of hypersensitivity to drugs of the same pharmacological classesof substances under investigation;